Vanda Pharmaceuticals Inc (VNDA) 14-day ATR is 0.31: This Stock is Set to Soar Above its Peers

Witnessing the stock’s movement on the chart, on Wednesday, Vanda Pharmaceuticals Inc (NASDAQ: VNDA) set off with pace as it heaved 29.16% to $5.05, before settling in for the price of $3.91 at the close. Taking a more long-term approach, VNDA posted a 52-week range of $3.30-$7.00.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 1.11%. Meanwhile, its Annual Earning per share during the time was -37.98%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -75.00%. This publicly-traded company’s shares outstanding now amounts to $57.53 million, simultaneously with a float of $54.51 million. The organization now has a market capitalization sitting at $290.58 million. At the time of writing, stock’s 50-day Moving Average stood at $4.02, while the 200-day Moving Average is $4.63.

Vanda Pharmaceuticals Inc (VNDA) Ownership Facts and Figures

Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Vanda Pharmaceuticals Inc’s current insider ownership accounts for 5.26%, in contrast to 89.15% institutional ownership. According to the most recent insider trade that took place on Mar 05 ’24, this organization’s President and CEO sold 24,288 shares at the rate of 4.13, making the entire transaction reach 100,273 in total value, affecting insider ownership by 1,871,730. Preceding that transaction, on Mar 05 ’24, Company’s SVP, Chief Marketing Officer sold 9,229 for 4.21, making the whole transaction’s value amount to 38,830. This particular insider is now the holder of 129,789 in total.

Vanda Pharmaceuticals Inc (VNDA) Earnings and Revenue Records

As on 12/30/2023, Multinational firm has announced its last quarter scores, in which it reported -$0.04 earnings per share (EPS) for the period topping the consensus outlook (set at -$0.09) by $0.05. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.02 per share during the current fiscal year.

Vanda Pharmaceuticals Inc’s EPS decrease for this current 12-month fiscal period is -75.00% and is forecasted to reach -0.48 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 36.10% through the next 5 years, which can be compared against the -37.98% growth it accomplished over the previous five years trading on the market.

Vanda Pharmaceuticals Inc (NASDAQ: VNDA) Trading Performance Indicators

Let’s observe the current performance indicators for Vanda Pharmaceuticals Inc (VNDA). It’s Quick Ratio in the last reported quarter now stands at 4.92. The Stock has managed to achieve an average true range (ATR) of 0.31. Alongside those numbers, its PE Ratio stands at $115.56, and its Beta score is 0.78. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1.51. Similarly, its price to free cash flow for trailing twelve months is now 23.40.

In the same vein, VNDA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.04, a figure that is expected to reach 0.05 in the next quarter, and analysts are predicting that it will be -0.48 at the market close of one year from today.

Technical Analysis of Vanda Pharmaceuticals Inc (VNDA)

Going through the that latest performance of [Vanda Pharmaceuticals Inc, VNDA]. Its last 5-days volume of 11.15 million indicated improvement to the volume of 1.77 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 57.11% While, its Average True Range was 0.39.

Raw Stochastic average of Vanda Pharmaceuticals Inc (VNDA) in the period of the previous 100 days is set at 64.17%, which indicates a major rise in contrast to 57.76% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 109.35% that was higher than 75.75% volatility it exhibited in the past 100-days period.